284
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Identification of differentially expressed genes and pathways between primary osteoarthritis and endemic osteoarthritis (Kashin–Beck disease)

, , , , &
Pages 71-79 | Accepted 25 May 2012, Published online: 17 Nov 2012

References

  • Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, . Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58:15–25.
  • Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 2009;60:3546–53.
  • Guo X, Zuo H, Cao CX, Zhang Y, Geng D, Zhang ZT, . Abnormal expression of Col X, PTHrP, TGF-beta, bFGF, and VEGF in cartilage with Kashin–Beck disease. J Bone Miner Metab 2006;24:319–28.
  • Wang S, Guo X, Tan WH, Geng D, Deng BP, Wang CE, . Detection of serum proteomic changes and discovery of serum biomarkers for Kashin–Beck disease using surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOF MS). J Bone Miner Metab 2008;26:385–93.
  • Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet 2005;365:965–73.
  • Sun W, Wang X, Zou X, Song R, Du X, Hu J, . Selenoprotein P gene r25191g/a polymorphism and quantification of selenoprotein P mRNA level in patients with Kashin–Beck disease. Br J Nutr 2010;104:1283–7.
  • Fairweather-Tait S, Bao Y, Broadley M, Collings R, Ford D, Hesketh J, . Selenium in human health and disease. Antioxid Redox Signal 2010;14:1337–83.
  • Downey CM, Horton CR, Carlson BA, Parsons TE, Hatfield DL, Hallgrimsson B, . Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin–Beck disease. PLoS Genet 2009;5:e1000616.
  • Chasseur C, Suetens C, Nolard N, Begaux F, Haubruge E. Fungal contamination in barley and Kashin–Beck disease in Tibet. Lancet 1997;350:1074.
  • Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545–50.
  • Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007;23:3251–3.
  • de Graaf CA, Kauppi M, Baldwin T, Hyland CD, Metcalf D, Willson TA, . Regulation of hematopoietic stem cells by their mature progeny. Proc Natl Acad Sci USA 2010;107:21689–94.
  • Chong HK, Infante AM, Seo YK, Jeon TI, Zhang Y, Edwards PA, . Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Res 2010;38:6007–17.
  • Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, . Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689–93.
  • Yang JB, Wang ZW, Liu JX. Diagnostic criteria of Kashin–Beck disease. Chin J Endemiol 1994;13:24–32.
  • Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635–41.
  • Alizadeh BZ, Njajou OT, Bijkerk C, Meulenbelt I, Wildt SC, Hofman A, . Evidence for a role of the genomic region of the gene encoding for the alpha1 chain of type IX collagen (COL9A1) in hip osteoarthritis: a population-based study. Arthritis Rheum 2005;52:1437–42.
  • Jakkula E, Melkoniemi M, Kiviranta I, Lohiniva J, Raina SS, Perala M, . The role of sequence variations within the genes encoding collagen II, IX and XI in non-syndromic, early-onset osteoarthritis. Osteoarthritis Cartilage 2005;13:497–507.
  • Ikeda T, Mabuchi A, Fukuda A, Kawakami A, Ryo Y, Yamamoto S, . Association analysis of single nucleotide polymorphisms in cartilage-specific collagen genes with knee and hip osteoarthritis in the Japanese population. J Bone Miner Res 2002;17:1290–6.
  • Riancho JA, Garcia-Ibarbia C, Gravani A, Raine EV, Rodriguez-Fontenla C, Soto-Hermida A, . Common variations in estrogen-related genes are associated with severe large-joint osteoarthritis: a multicenter genetic and functional study. Osteoarthritis Cartilage 2010;18:927–33.
  • Lo SF, Huang CM, Lin HC, Tsai CH, Tsai FJ. Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan. Rheumatol Int 2005;25:580–4.
  • Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007;27:339–44.
  • Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T, . Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006;54:3533–44.
  • Walford GA, Moussignac RL, Scribner AW, Loscalzo J, Leopold JA. Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J Biol Chem 2004;279:4425–32.
  • Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000;5:415–18.
  • Henrotin Y, Kurz B, Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage 2005;13:643–54.
  • Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000;275:20069–76.
  • Del Carlo M Jr, Loeser RF. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 2002;46:394–403.
  • Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, Chan K, . Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 2011;70:844–50.
  • Suh JK, Poulsen LL, Ziegler DM, Robertus JD. Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum. Proc Natl Acad Sci USA 1999;96:2687–91.
  • Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191–212.
  • Pufe T, Petersen W, Tillmann B, Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001;44:1082–8.
  • Pfander D, Kortje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, . Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 2001;60:1070–3.
  • Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, . Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003;162:171–81.
  • Wang WZ, Guo X, Duan C, Ma WJ, Zhang YG, Xu P, . Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthritis Cartilage 2009;17:83–90.
  • Pufe T, Harde V, Petersen W, Goldring MB, Tillmann B, Mentlein R. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 2004;202:367–74.
  • Fay J, Varoga D, Wruck CJ, Kurz B, Goldring MB, Pufe T. Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res Ther 2006;8:R189.
  • Zhang BD, Guo X, Bai GL, Ping ZG, Zuo H, Ren FL. The changes of nitric oxide, NO synthase and sFas/APO-1 in serum among the patients with Kashin–Beck disease. Chin J Endemiol 2004;23:172–5.
  • Wang SJ, Guo X, Zuo H, Zhang YG, Xu P, Ping ZG, . Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin–Beck disease. J Rheumatol 2006;33:615–19.
  • Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75–85.
  • van’t Hof RJ, Hocking L, Wright PK, Ralston SH. Nitric oxide is a mediator of apoptosis in the rheumatoid joint. Rheumatology (Oxford) 2000;39:1004–8.
  • Lee SW, Lee HJ, Chung WT, Choi SM, Rhyu SH, Kim DK, . TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Arthritis Rheum 2004;50:534–42.
  • Huerta-Yepez S, Vega M, Escoto-Chavez SE, Murdock B, Sakai T, Baritaki S, . Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide 2009;20:39–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.